Literature DB >> 35649251

Defining the versican interactome in lung health and disease.

Fengying Tang1,2, Jourdan E Brune1,2, Mary Y Chang1,2, Stephen R Reeves3,4, William A Altemeier1,5, Charles W Frevert1,2,5.   

Abstract

The extracellular matrix (ECM) imparts critical mechanical and biochemical information to cells in the lungs. Proteoglycans are essential constituents of the ECM and play a crucial role in controlling numerous biological processes, including regulating cellular phenotype and function. Versican, a chondroitin sulfate proteoglycan required for embryonic development, is almost absent from mature, healthy lungs and is reexpressed and accumulates in acute and chronic lung disease. Studies using genetically engineered mice show that the versican-enriched matrix can be pro- or anti-inflammatory depending on the cellular source or disease process studied. The mechanisms whereby versican develops a contextual ECM remain largely unknown. The primary goal of this review is to provide an overview of the interaction of versican with its many binding partners, the "versican interactome," and how through these interactions, versican is an integrator of complex extracellular information. Hopefully, the information provided in this review will be used to develop future studies to determine how versican and its binding partners can develop contextual ECMs that control select biological processes. Although this review focuses on versican and the lungs, what is described can be extended to other proteoglycans, tissues, and organs.

Entities:  

Keywords:  extracellular matrix; microenvironments; versican interactome

Mesh:

Substances:

Year:  2022        PMID: 35649251      PMCID: PMC9291419          DOI: 10.1152/ajpcell.00162.2022

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  365 in total

Review 1.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

2.  Consequences of lack of beta 1 integrin gene expression in mice.

Authors:  R Fässler; M Meyer
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

Review 3.  Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases.

Authors:  Nikos K Karamanos; Achilleas D Theocharis; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2018-08-18       Impact factor: 11.583

Review 4.  Is asthma a fibrotic disease?

Authors:  C R Roberts
Journal:  Chest       Date:  1995-03       Impact factor: 9.410

5.  Neutrophil margination, sequestration, and emigration in the lungs of L-selectin-deficient mice.

Authors:  N A Doyle; S D Bhagwan; B B Meek; G J Kutkoski; D A Steeber; T F Tedder; C M Doerschuk
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

Review 6.  Leukocyte Adhesion: Reconceptualizing Chemokine Presentation by Glycosaminoglycans.

Authors:  Gerard J Graham; Tracy M Handel; Amanda E I Proudfoot
Journal:  Trends Immunol       Date:  2019-04-18       Impact factor: 16.687

7.  Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid.

Authors:  F Binette; J Cravens; B Kahoussi; D R Haudenschild; P F Goetinck
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

8.  The chicken neural extracellular matrix molecule restrictin: similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs.

Authors:  U Nörenberg; H Wille; J M Wolff; R Frank; F G Rathjen
Journal:  Neuron       Date:  1992-05       Impact factor: 17.173

9.  Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor.

Authors:  P J Miettinen; J E Berger; J Meneses; Y Phung; R A Pedersen; Z Werb; R Derynck
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

10.  Matricellular proteins: an overview.

Authors:  Paul Bornstein
Journal:  J Cell Commun Signal       Date:  2009-09-25       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.